COVID-19 and anosmia: A review based on up-to-date knowledge
- PMID: 32563019
- PMCID: PMC7265845
- DOI: 10.1016/j.amjoto.2020.102581
COVID-19 and anosmia: A review based on up-to-date knowledge
Abstract
The pandemic of Coronavirus Disease 2019 (COVID-19) has caused a vast disaster throughout the world. There is increasing evidence that olfactory dysfunction can present in COVID-19 patients. Anosmia can occur alone or can be accompanied by other symptoms of COVID-19, such as a dry cough. However, the pathogenic mechanism of olfactory dysfunction and its clinical characteristics in patients with COVID-19 remains unclear. Multiple cross-sectional studies have demonstrated that the incidence rate of olfactory dysfunction in COVID-19 patients varies from 33.9-68% with female dominance. Anosmia and dysgeusia are often comorbid in COVID-19 patients. Otolaryngologists should be mindful of the symptom of anosmia in outpatients so as not to delay the diagnosis of COVID-19. In this paper, we have reviewed the relevant knowledge based on up-to-date literature.
Keywords: Anosmia; COVID-19; Coronavirus; Olfactory dysfunction; Otolaryngology; SARS-CoV-2; Smell.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no competing interests.
References
-
- World Health Organization Coronavirus disease 2019 (COVID-19) situation report-104. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
-
- World Health Organization WHO Director-General's remarks at the media briefing on2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
